Shenglin Luo

4.1k total citations · 1 hit paper
56 papers, 3.4k citations indexed

About

Shenglin Luo is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Materials Chemistry. According to data from OpenAlex, Shenglin Luo has authored 56 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Biomedical Engineering, 20 papers in Pulmonary and Respiratory Medicine and 15 papers in Materials Chemistry. Recurrent topics in Shenglin Luo's work include Nanoplatforms for cancer theranostics (34 papers), Photodynamic Therapy Research Studies (16 papers) and Advanced Nanomaterials in Catalysis (8 papers). Shenglin Luo is often cited by papers focused on Nanoplatforms for cancer theranostics (34 papers), Photodynamic Therapy Research Studies (16 papers) and Advanced Nanomaterials in Catalysis (8 papers). Shenglin Luo collaborates with scholars based in China, United States and Vietnam. Shenglin Luo's co-authors include Chunmeng Shi, Yongping Su, Tianmin Cheng, Erlong Zhang, Xu Tan, Tao Liu, Yu Wang, Rong Li, Dechun Wang and Sheng‐Tao Fang and has published in prestigious journals such as Advanced Materials, ACS Nano and Biomaterials.

In The Last Decade

Shenglin Luo

54 papers receiving 3.4k citations

Hit Papers

A review of NIR dyes in cancer targeting and imaging 2011 2026 2016 2021 2011 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenglin Luo China 26 2.4k 1.4k 847 810 534 56 3.4k
Yongdoo Choi South Korea 38 2.6k 1.1× 1.9k 1.4× 874 1.0× 1.3k 1.6× 917 1.7× 101 4.6k
Penghui Cheng Singapore 27 2.5k 1.1× 1.3k 1.0× 545 0.6× 1.1k 1.4× 505 0.9× 48 3.5k
Yufu Tang China 29 1.9k 0.8× 1.4k 1.1× 457 0.5× 675 0.8× 266 0.5× 79 2.9k
Leu‐Wei Lo Taiwan 36 2.0k 0.9× 1.7k 1.2× 526 0.6× 1.2k 1.5× 1.5k 2.8× 85 4.5k
Zhifei Dai China 42 3.0k 1.3× 1.7k 1.3× 714 0.8× 1.2k 1.4× 1.5k 2.8× 121 4.9k
Subin Son South Korea 18 1.9k 0.8× 1.2k 0.9× 446 0.5× 719 0.9× 382 0.7× 25 2.7k
Chongwei Chi China 30 2.6k 1.1× 1.3k 0.9× 628 0.7× 681 0.8× 476 0.9× 68 3.8k
Hui Zhou China 39 2.1k 0.9× 2.5k 1.9× 359 0.4× 1.1k 1.3× 329 0.6× 128 4.9k
Erlong Zhang China 17 1.1k 0.5× 675 0.5× 442 0.5× 651 0.8× 288 0.5× 37 2.2k
Jiyou Han South Korea 29 1.4k 0.6× 841 0.6× 357 0.4× 1.0k 1.3× 429 0.8× 58 2.8k

Countries citing papers authored by Shenglin Luo

Since Specialization
Citations

This map shows the geographic impact of Shenglin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglin Luo more than expected).

Fields of papers citing papers by Shenglin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglin Luo. The network helps show where Shenglin Luo may publish in the future.

Co-authorship network of co-authors of Shenglin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglin Luo. A scholar is included among the top collaborators of Shenglin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglin Luo. Shenglin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Weidong, Mingquan Gao, Banghui Mo, et al.. (2025). Endoplasmic Reticulum-Targeted Phototherapy Remodels the Tumor Immunopeptidome to Enhance Immunogenic Cell Death and Adaptive Anti-Tumor Immunity. Pharmaceuticals. 18(4). 491–491. 2 indexed citations
2.
Liu, Jing, et al.. (2025). MSC-EXs inhibits uranium nephrotoxicity by competitively binding key proteins and inhibiting ROS production. Ecotoxicology and Environmental Safety. 289. 117654–117654. 4 indexed citations
3.
Gao, Mingquan, Weidong Xiao, Banghui Mo, et al.. (2024). Albumin tailoring molecular rotation and electrophilicity of a GSH-depleting radiosensitizer for potentiating ferroptosis-mediated radioimmunotherapy. Chemical Engineering Journal. 495. 153595–153595. 3 indexed citations
4.
Ren, Yingying, et al.. (2024). Study for Photo-Induced Enhanced Raman Spectroscopy with Laser-Induced Periodic Surface Structures on Lithium Niobate on Insulator. The Journal of Physical Chemistry Letters. 15(24). 6458–6466. 1 indexed citations
5.
Gao, Mingquan, et al.. (2024). Asymmetrically PEGylated and amphipathic heptamethine indocyanine dyes potentiate radiotherapy of renal cell carcinoma via mitochondrial targeting. Journal of Nanobiotechnology. 22(1). 756–756. 2 indexed citations
6.
Tan, Xu, Yu Wang, Lei Long, et al.. (2024). A theranostic photosensitizer-conjugated albumin co-loading with resiquimod for cancer-targeted imaging and robust photo-immunotherapy. Pharmacological Research. 210. 107489–107489. 3 indexed citations
8.
Ren, Yingying, Peng An, Shenglin Luo, et al.. (2023). Femtosecond laser induced periodic surface structures on crystals: Formation, evolution and application. Vacuum. 221. 112900–112900. 2 indexed citations
9.
Li, Yang, et al.. (2023). The Use of Hydrogel-Based Materials for Radioprotection. Gels. 9(4). 301–301. 7 indexed citations
11.
Zhang, Chi, Tao Liu, Peng Luo, et al.. (2021). Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy. Science Advances. 7(1). 24 indexed citations
12.
Luo, Peng, Xu Tan, Shenglin Luo, et al.. (2019). An NIR‐Fluorophore‐Based Inhibitor of SOD1 Induces Apoptosis by Targeting Transcription Cofactor PC4. Advanced Therapeutics. 2(5).
13.
Wang, Yang, Xingyun Liao, Jianguo Sun, et al.. (2018). Characterization of HIF‐1α/Glycolysis Hyperactive Cell Population via Small‐Molecule‐Based Imaging of Mitochondrial Transporter Activity. Advanced Science. 5(3). 1700392–1700392. 28 indexed citations
14.
Wang, Yang, Shenglin Luo, Chi Zhang, et al.. (2018). An NIR‐Fluorophore‐Based Therapeutic Endoplasmic Reticulum Stress Inducer. Advanced Materials. 30(33). e1800475–e1800475. 42 indexed citations
15.
Tan, Xu, Shenglin Luo, Lei Long, et al.. (2017). Structure‐Guided Design and Synthesis of a Mitochondria‐Targeting Near‐Infrared Fluorophore with Multimodal Therapeutic Activities. Advanced Materials. 29(43). 195 indexed citations
16.
17.
Wang, Yang, Tao Liu, Erlong Zhang, et al.. (2014). Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells. Biomaterials. 35(13). 4116–4124. 115 indexed citations
18.
Shi, Chunmeng, Tao Liu, Shenglin Luo, et al.. (2014). Synthesis and characterization of a glycine- modified heptamethine indocyanine dye for in vivo cancer-targeted near-infrared imaging. Drug Design Development and Therapy. 8. 1287–1287. 11 indexed citations
19.
Zhang, Erlong, Shenglin Luo, Xu Tan, & Chunmeng Shi. (2013). Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent. Biomaterials. 35(2). 771–778. 198 indexed citations
20.
Luo, Shenglin, Xu Tan, Qingrong Qi, et al.. (2012). A multifunctional heptamethine near-infrared dye for cancer theranosis. Biomaterials. 34(9). 2244–2251. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026